Andreas Munk Petersen

Medicine & Life Sciences

1. Inflammatory Bowel Diseases 100%
2. Escherichia coli 74%
3. Fecal Microbiota Transplantation 65%
4. Crohn Disease 53%
5. Ulcerative Colitis 51%
6. Diarrhea 44%
7. Microbiota 39%
8. Denmark 38%
9. Gastrointestinal Microbiome 36%
10. Disease Outbreaks 34%
11. Helicobacter pylori 34%
12. Hemolytic-Uremic Syndrome 32%
13. MGN1703 31%
14. Anti-Bacterial Agents 31%
15. Saccharomyces boulardii 28%
16. Child 27%
17. Leukocyte L1 Antigen Complex 26%
18. Gastroenteritis 26%
19. Clostridium Infections 25%
20. Serogroup 25%
21. Toll-Like Receptor 9 24%
22. Irritable Bowel Syndrome 24%
23. Escherichia coli O104 24%
24. Escherichia coli Infections 24%
25. Placebos 23%
26. Child Day Care Centers 22%
27. Pneumococcal Vaccines 22%
28. Ciprofloxacin 21%
29. Cohort Studies 20%
30. Virulence 20%
31. Probiotics 19%
32. Systematic Reviews 19%
33. Capsules 19%
34. Extraintestinal Pathogenic Escherichia coli 18%
35. Therapeutics 18%
36. Dientamoebiasis 18%
37. Whole Genome Sequencing 16%
38. Epidemiology 16%
39. Dysbiosis 16%
40. OmpC protein 15%
41. Dientamoeba 15%